Diagnostic Imaging Devices - New Zealand

The Diagnostic Imaging Devices market market in New Zealand is expected to achieve a revenue of NZD US$124.50m in 2024.
It is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.76% from 2024 to 2029, reaching a market volume of NZD US$157.10m by 2029.
Comparatively, the United States will generate the highest revenue globally, amounting to US$11.93bn in 2024.
New Zealand's diagnostic imaging device market is experiencing a surge in demand due to the country's growing aging population.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in New Zealand is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Diagnostic Imaging Devices market in New Zealand are shifting towards more advanced and innovative technologies. Customers are increasingly looking for devices that offer higher image quality, faster scanning times, and improved patient comfort. This is driving the demand for advanced imaging modalities such as MRI, CT scans, and ultrasound machines. Additionally, there is a growing preference for portable and handheld devices that can be used in remote areas or in ambulatory settings. Trends in the market are also contributing to the growth of the Diagnostic Imaging Devices market in New Zealand. One major trend is the increasing adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, easier storage and retrieval of images, and the ability to enhance and manipulate images for better diagnosis. This trend is driving the demand for digital X-ray systems, digital mammography systems, and digital ultrasound machines. Another trend in the market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into diagnostic imaging devices. AI and ML algorithms can analyze medical images and assist radiologists in detecting abnormalities and making accurate diagnoses. This trend is expected to improve the efficiency and accuracy of diagnostic imaging, leading to better patient outcomes. Local special circumstances in New Zealand, such as the country's aging population and the increasing prevalence of chronic diseases, are also driving the growth of the Diagnostic Imaging Devices market. As the population ages, there is a higher demand for diagnostic imaging services to detect and monitor age-related conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders. Additionally, the rising incidence of chronic diseases, such as diabetes and respiratory diseases, is increasing the need for diagnostic imaging devices for early detection and monitoring of these conditions. Underlying macroeconomic factors, such as favorable government policies and investments in healthcare infrastructure, are further supporting the growth of the Diagnostic Imaging Devices market in New Zealand. The government has been actively investing in healthcare infrastructure to improve access to healthcare services, including diagnostic imaging. This includes the development of new hospitals and medical centers, as well as the upgrade of existing facilities. These investments are expected to drive the demand for diagnostic imaging devices in the country. In conclusion, the Diagnostic Imaging Devices market in New Zealand is experiencing steady growth due to customer preferences for advanced technologies, trends in the market such as digital imaging and AI integration, local special circumstances such as an aging population and increasing prevalence of chronic diseases, and underlying macroeconomic factors such as government investments in healthcare infrastructure.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.